日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award

医学博士、哲学博士赛勒斯·A·拉吉荣获2025年马克·A·史密斯阿尔茨海默病奖。

Mattsson, N; Rosén, E; Hansson, O; Andreasen, N; Parnetti, L; Jonsson, M; Herukka, S-K; van der Flier, W M; Blankenstein, M A; Ewers, M; Rich, K; Kaiser, E; Verbeek, M M; Olde Rikkert, M; Tsolaki, M; Mulugeta, E; Aarsland, D; Visser, P J; Schröder, J; Marcusson, J; de Leon, M; Hampel, H; Scheltens, P; Wallin, A; Eriksdotter-Jönhagen, M; Minthon, L; Winblad, B; Blennow, K; Zetterberg, H

Brain injury biomarkers and intraoperative hypotension: associations with pituitary hormone deficiency following transsphenoidal endoscopic surgery for non-functioning pituitary adenomas

脑损伤生物标志物和术中低血压:与经蝶窦内镜手术治疗无功能性垂体腺瘤后垂体激素缺乏症的相关性

Thorsson, Martin; Trimpou, P; Asztély, M; Hallén, T; Hantelius, V; Blennow, K; Zetterberg, H; Johannsson, G; Oras, J; Skoglund, T

The impact of cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline

心肺适能对阿尔茨海默病生物标志物的影响及其与认知衰退的关系

Paulsen, A J; Driscoll, I; Breidenbach, B M; Glittenberg, M P; Lose, S R; Ma, Y; Sager, M A; Carlsson, C M; Gallagher, C L; Hermann, B P; Blennow, K; Zetterberg, H; Asthana, S; Johnson, S C; Betthauser, T J; Christian, B T; Cook, D B; Okonkwo, O C

Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study

血清神经丝轻链用于检测多发性硬化症患者个体疾病活动性:一项为期 48 周的前瞻性单中心研究

Johnsson, M; Stenberg, Y T; Farman, H H; Blennow, K; Zetterberg, H; Malmeström, C; Sandgren, S; Rosenstein, I; Lycke, J; Axelsson, M; Novakova, L

Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus

特发性正常压力脑积水患者的血浆和脑脊液中神经丝轻链蛋白浓度呈正相关

Jeppsson, A; Sandelius, Å; Zettergren, A; Kern, S; Skoog, I; Blennow, K; Zetterberg, H; Wikkelsø, C; Hellström, P; Tullberg, M

Effect of a 1-Year Nutritional Blend Supplementation on Plasma p-tau181 and GFAP Levels among Community-Dwelling Older Adults: A Secondary Analysis of the Nolan Trial

为期一年的营养混合物补充剂对社区老年人血浆 p-tau181 和 GFAP 水平的影响:Nolan 试验的二次分析

Giudici, K V; de Souto Barreto, P; Guyonnet, S; Cantet, C; Zetterberg, H; Boschat, C; Hudry, J; Andrieu, S; Schmitt, J A J; Vellas, B; Blennow, K

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

2020年关于脑脊液淀粉样蛋白、tau蛋白和磷酸化tau蛋白作为阿尔茨海默病生物标志物的临床有效性的最新进展,该进展基于一个结构化的五阶段开发框架。

Leuzy, A; Ashton, N J; Mattsson-Carlgren, N; Dodich, A; Boccardi, M; Corre, J; Drzezga, A; Nordberg, A; Ossenkoppele, R; Zetterberg, H; Blennow, K; Frisoni, G B; Garibotto, V; Hansson, O

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

利用阿尔茨海默病生物标志物五阶段开发框架评估淀粉样蛋白和磷酸化tau蛋白血液生物标志物的验证状态

Ashton, N J; Leuzy, A; Karikari, T K; Mattsson-Carlgren, N; Dodich, A; Boccardi, M; Corre, J; Drzezga, A; Nordberg, A; Ossenkoppele, R; Zetterberg, H; Blennow, K; Frisoni, G B; Garibotto, V; Hansson, O

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

对神经退行性疾病患者脑脊液中总载脂蛋白E及其亚型进行定量分析

Minta, K; Brinkmalm, G; Janelidze, S; Sjödin, S; Portelius, E; Stomrud, E; Zetterberg, H; Blennow, K; Hansson, O; Andreasson, U

Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease

多巴胺相关基因多态性与帕金森病认知功能下降

Bäckström, D; Eriksson Domellöf, M; Granåsen, G; Linder, J; Mayans, S; Elgh, E; Zetterberg, H; Blennow, K; Forsgren, L